Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 11 - The Untold Story

7 Prescription Drug Costs to Compare Before Medicare Open Enrollment

A Medicare drug plan that looks inexpensive on the surface can become surprisingly costly once you start filling prescriptions. Premiums are only one piece of...

Saving Advice · Aug 9

Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue

Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer, manufacturing and supply of sterile injectable products. The agreement covers 55 SKUs across three sites, with annualised revenue potential of $90-100 million upon commercialisation. Revenue generation is expected to begin in…

The Economic Times · Aug 9

MarketBeat Week in Review – 08/03 - 08/07

A weekly roundup of MarketBeat analysis covering earnings from AbbVie, AMD, Palantir, Meta, Reddit, SpaceX and others, plus upcoming CPI and PPI inflation data.

MarketBeat · Aug 8

From analysis to the latest developments in health,
read the most diverse news in one place.

Global Market | Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data

On Friday, Europe's STOXX 600 index marked its fourth consecutive record closing, driven primarily by technology stocks that mirrored the strong performance of Wall Street. The recent U.S. jobs data, which suggested a slower labor market, has diminished the likelihood of an interest rate hike from the Federal Reserve this…

The Economic Times · Aug 8

FDA Reorganization Takes Effect October 1, with Inspector Specialization Set to End

FDA will merge specialized field inspectors into a generalist pool and centralize administration on October 1. What inspectors check and how to look up a manufacturer.

Medical Daily · Aug 8

Federal Pilot Would Replace Upfront 340B Discounts with Rebates for a Small Set of Drugs

HRSA will test paying 340B discounts as rebates instead of upfront price cuts starting January 2027. Manufacturers must apply by August 24.

Medical Daily · Aug 8

Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients

Amazon.com Inc.‘s (NASDAQ:AMZN) Amazon Pharmacy will offer eligible Medicare beneficiaries weight-loss drugs for $50 per month through a new federal program aimed at expanding access.

Benzinga · Aug 7

Read news from The Economist, FT, and more,
with one subscription

Forget Nvidia chips, China's next big race is being slowed down by an unlikely rival: monkeys

Lab primate prices in China have surged over 1,000% in eight years, with a single cynomolgus macaque now costing around Rs 22 lakh. The shortage is delaying preclinical drug trials by up to ten months, projected to persist until 2028, and is now being compared by industry insiders to the…

The Economic Times · Aug 7

Lilly Says Weight Loss Drug Prices Fell 13 Percent Worldwide, but the US Decline Was Far Smaller

Lilly reported a 13% drop in realized prices, but US prices fell only 3%. Here is what that means for Zepbound patients and out-of-pocket costs.

Medical Daily · Aug 6

Soriot should explain the curious case of AstraZeneca’s non-deal

AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholders

The Guardian - UK · Aug 5

California Supreme Court Rules Gilead Had No Legal Duty to Bring a Newer HIV Drug to Market Sooner

California's high court rejected a duty-to-innovate claim from about 24,000 HIV patients. Here is what the ruling does and does not decide.

Medical Daily · Aug 5

Global Market: European shares climb as earnings, US-Iran diplomacy lift sentiment

European stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased for investors. Novo Nordisk shares fell despite an improved outlook due to drug trial setbacks. Sandoz surged on strong second-quarter net sales, boosting healthcare stocks. Siemens Energy also gained following record…

The Economic Times · Aug 5

Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipeline

Novo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline after recent trial setbacks. The company raised its 2026 sales and profit outlook, but shares fell as investors focused on weaker-than-expected Wegovy pill sales and another setback for obesity…

The Economic Times · Aug 5

Novo Nordisk Stock Slides After Outlook Disappoints. But Wegovy Sales Continue to Climb

U.S.-listed shares of Novo Nordisk fell more than 6% after the company raised its full-year 2026 outlook but signaled that sales and profit could still decline compared with the previous year.

International Business Times · Aug 4

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Aug 4

Ozempic Maker Novo Nordisk Raises Outlook but Sales Fall on Tough Comparison, Stock Tanks

Novo Nordisk A/S (NYSE:NVO) stock is trading lower on Tuesday despite the company raising its fiscal 2026 guidance.

Medical Daily · Aug 4

A Next-Generation Obesity Drug Has Been Released By Eli Lilly in Early Access to Select Patients

Eli Lilly will offer early access to the investigational obesity drug retatrutide after positive Phase 3 trials showed significant weight-loss results.

The Economic Times · Aug 4

Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts

Pfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical products. The company is planning $2.5 billion in cost-saving measures expected to be in place by 2029. With a focus on innovative treatments, Pfizer aims to reduce reliance on older, high-grossing medications and looks…

Medical Daily · Aug 4

Federal 340B Rebate Pilot Set for January 1 Could Change How Safety-Net Hospitals Fund Patient Programs

HRSA revived its 340B rebate pilot for January 1, 2027. Here is how the payment change could affect safety-net hospital programs and patients.

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times · Aug 4

India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says

India's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncertainty and Middle East shipping disruptions hurt exports, Pharmaceuticals Export Promotion Council of India Chairman Namit Joshi told Reuters.

Medical Daily · Aug 3

FDA Flags Two Separate Class I Corrections for Hospital Infusion Pumps That Deliver Chemotherapy and Antibiotics

FDA posted two Class I corrections for Ivenix infusion pumps used to give chemotherapy, antibiotics and pain medicine. What patients should ask.

The Guardian - UK · Aug 3

AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger

The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling

Medical Daily · Aug 3

Three Injectable Drug Recalls Landed on the Same Day, Including a Widely Used Cancer Drug

Three injectable medicines were recalled July 24, including a chemotherapy drug with steel particles. What patients and caregivers should know.

Benzinga · Aug 3

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

As per a media report over the weekend, AstraZeneca Plc (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) are in potential discussions to form a pharmaceutical giant valued at nearly $400 billion.

Medical Daily · Aug 3

Patients Waiting Out Drug Shortages Have a Stake in an Obscure FDA Registration Proposal

A quiet FDA rulemaking would require more foreign drug plants to register. Better upstream visibility is how shortages get caught earlier.

Evening Standard · Aug 3

AstraZeneca in talks over £300bn mega-merger with US rival – reports

The move would mark one of the industry’s largest ever deals and create the world’s fourth largest pharmaceutical company.

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations